Nectar Lifesciences Limited -1.66 % Drug Manufacturers - Major

Trend Analysis


Support and Resistance Levels Analysis
The current close value 17.8 is between the support and resistance channel of 018 and 018. The stock has a Sell Signal , 018 becomes a critical support to stop the fall and 018 is a immediate resistance on the upside.

Technical Indicators (3 Month duration)
Exponential Moving average 18.1
MACD value 0.1
Price range 15.90 to 20.65
Volume range 55770 to 163684
Support & Resistance 18, 18
Stock Performance
Six Months -18.2%
Five Months-20.0%
Four Months-15.4%
Three Months-11.4%
Two Months-4.3%
One Month3.5%
Last Six Months


Last Five Months


Last Four Months


Last Three Months


Last Two Months


Last One Month


Today's Price Range
3 Month Price Range
About Nectar Lifesciences Limited
Nectar Lifesciences Limited (Neclife) is an India-based pharmaceutical company. The Company's business activities include Contract Research and Manufacturing Services, APIs and Intermediates, Formulations, Generics and Over-The-Counter (OTC), Diagnostics, Hard Gelatin Capsules and Menthol. The Company's is focused on manufacturing and marketing of oral and sterile cephalosporin intermediates, active pharmaceutical ingredients (APIs) and finished dosage formulations. It also manufactures capsules and natural menthol. The Company offers contract manufacturing services for products from development through to bulk production and In-Vitro Diagnostics. Some of the services offered the Company include Process development and optimization, Process scale up and validation, Preparation and submission of Drug Master Files, among others.
See stocks similar to Nectar Lifesciences Limited in Drug Manufacturers - Major

Nectar Lifesciences Limited has Sell Signal. What is your opinion on it?

{ }